Literature DB >> 6969731

Impaired 24,25-dihydroxyvitamin D production in anephric human and pig.

R L Horst, E T Littledike, R W Gray, J L Napoli.   

Abstract

Plasma 25-hydroxyvitamin D and 24, 25-dihydroxy-vitamin D [24,25-(OH)(2)D] concentrations were measured in normal and chronically dialyzed anephric humans and pigs. Measurement of the 24, 25-(OH)(2)D was preceded by three purification steps involving one Sephadex LH-20 column and two high-pressure liquid chromatographic columns. The final high-pressure liquid chromatography step involved resolution of 25-hydroxy-vitamin D(3)-26,23 lactone and 25,26-dihydroxy-vitamin D(2) from 24,25-dihydroxyvitamin D(2) and 24,25-dihydroxyvitamin D(3) [24,25-(OH)(2)D(3)]. The total 25-hydroxyvitamin D [25-hydroxyvitamin D(2) plus 25-hydroxyvitamin D(3) (25-OHD(3))] was 31.7+/-3.6 ng/ml in the plasma of eight anephric human subjects and 40.1+/-3.7 ng/ml in five normal human subjects. Six of the eight anephric patients had undetectable (<0.2 ng/ml) 24,25-(OH)(2)D concentrations. Two of the eight patients had very low (0.51 and 0.41 ng/ml), but detectable, 24,25-dihydroxyvitamin D(2). The normal human volunteers had plasma 24,25-(OH)(2)D concentrations of 2.8+/-0.7 ng/ml. Chronically dialyzed anephric and normal pigs were given intramuscular injections of massive amounts (5 x 10(6) IU) of vitamin D(3) immediately after surgery (day 0) and again on day 7. In anephric pigs, plasma 25-OHD(3) progressively rose from 12+/-4 ng/ml on day 0 to 705+/-62 ng/ml on day 10. The 25-OHD(3) concentrations in normal pigs rose from 8+/-2 ng/ml on day 0 to 439+/-64 ng/ml on day 10. Plasma 25-OHD(3) was higher in anephrics throughout the experiment, and concentrations were significantly higher (P < 0.05) on days 9 and 10. Plasma 24,25-(OH)(2)D(3) concentrations declined progressively in anephric pigs from 3.6+/-0.6 ng/ml on day 0 to 3.2+/-0.7 ng/ml on day 2. During days 4-10, plasma 24,25-(OH)(2)D(3) was not apparent until plasma 25-OHD(3) was >400 ng/ml. In control pigs, plasma 24,25-(OH)(2)D(3) was elevated from 4.3+/-0.6 ng/ml on day 0 to 178+/-2.7 ng/ml on day 3. Plasma 24,25-(OH)(2)D(3) was significantly higher (P < 0.05) in controls on days 1-8. At the end of the experiment (day 10), 24,25-(OH)(2)D(3) concentrations were similar and not significantly different in both groups (87.0+/-18.4 ng/ml in anephric and 110.3+/-32.1 ng/ml in normal pigs). The identity of the 24,25-(OH)(2)D(3) isolated from anephric pig plasma was confirmed by mass spectroscopy. Our data suggest that anephric humans receiving normal dietary levels of vitamin D(3) have little or no ability to produce 24,25-(OH)(2)D. However, we have shown that pigs produce 24,25-(OH)(2)D(3) when plasma 25-OHD(3) is extremely high (>400 ng/ml).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6969731      PMCID: PMC371597          DOI: 10.1172/JCI110023

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.

Authors:  S Balsan; M Garabedian; R Sorgniard; M F Holick; H F Deluca
Journal:  Pediatr Res       Date:  1975-07       Impact factor: 3.756

2.  Competitive protein-binding radioassay of 24,25-dihydroxyvitamin D in sera from normal and anephric subjects.

Authors:  J G Haddad; C Min; M Mendelsohn; E Slatopolsky; T J Hahn
Journal:  Arch Biochem Biophys       Date:  1977-08       Impact factor: 4.013

3.  Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney.

Authors:  M F Holick; H K Schnoes; H F DeLuca; R W Gray; I T Boyle; T Suda
Journal:  Biochemistry       Date:  1972-11-07       Impact factor: 3.162

4.  Unique biosynthesis by kidney of a biological active vitamin D metabolite.

Authors:  D R Fraser; E Kodicek
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

5.  The determination of 24,25-dihydroxyvitamin D and 25,26-dihydroxyvitamin D in plasma from normal and nephrectomized man.

Authors:  R L Horst; R M Shepard; N A Jorgensen; H F DeLuca
Journal:  J Lab Clin Med       Date:  1979-02

6.  The vitamin D system in the regulation of calcium and phosphorus metabolism.

Authors:  H F DeLuca
Journal:  Nutr Rev       Date:  1979-06       Impact factor: 7.110

7.  25-Hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties.

Authors:  J C Knutson; H F DeLuca
Journal:  Biochemistry       Date:  1974-03-26       Impact factor: 3.162

8.  Determination of vitamin D and its metabolites in plasma from normal and anephric man.

Authors:  R M Shepard; R L Horst; A J Hamstra; H F DeLuca
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

9.  Metabolism of 25-hydroxyvitamin D3 in anephric rats: a new active metabolite.

Authors:  M Garabedian; H Pavlovitch; C Fellot; S Balsan
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

10.  Vitamin D metabolites and bone mineralization in man.

Authors:  P Bordier; H Rasmussen; P Marie; L Miravet; J Gueris; A Ryckwaert
Journal:  J Clin Endocrinol Metab       Date:  1978-02       Impact factor: 5.958

View more
  15 in total

1.  Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.

Authors:  Jason R Stubbs; Shiqin Zhang; Peter A Friedman; Thomas D Nolin
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-02       Impact factor: 8.237

2.  1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.

Authors:  Galina Nesterova; May Christine Malicdan; Kaori Yasuda; Toshiyuki Sakaki; Thierry Vilboux; Carla Ciccone; Ronald Horst; Yan Huang; Gretchen Golas; Wendy Introne; Marjan Huizing; David Adams; Cornelius F Boerkoel; Michael T Collins; William A Gahl
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-04       Impact factor: 8.237

3.  Extrarenal metabolism of 25-hydroxycholecalciferol in the rat: regulation by 1,25-dihydroxycholecalciferol.

Authors:  R T Turner; R C Avioli; N H Bell
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

Review 4.  Vitamin D and metabolites measurement by tandem mass spectrometry.

Authors:  Johannes M W van den Ouweland; Michael Vogeser; Silvia Bächer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

5.  Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.

Authors:  Hala Alshayeb; Arif Showkat; Barry M Wall; Geeta G Gyamlani; Valentin David; L Darryl Quarles
Journal:  J Clin Endocrinol Metab       Date:  2014-06-24       Impact factor: 5.958

6.  Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.

Authors:  Peter J Tebben; Dawn S Milliner; Ronald L Horst; Peter C Harris; Ravinder J Singh; Yanhong Wu; John W Foreman; Paul R Chelminski; Rajiv Kumar
Journal:  J Clin Endocrinol Metab       Date:  2012-02-15       Impact factor: 5.958

7.  Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.

Authors:  B P Halloran; D D Bikle; M J Levens; M E Castro; R K Globus; E Holton
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 8.  Impaired vitamin D metabolism in CKD.

Authors:  Cortney Bosworth; Ian H de Boer
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

9.  Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.

Authors:  Ian H de Boer; Michael C Sachs; Michel Chonchol; Jonathan Himmelfarb; Andrew N Hoofnagle; Joachim H Ix; Robin A Kremsdorf; Yvonne S Lin; Rajnish Mehrotra; Cassianne Robinson-Cohen; David S Siscovick; Michael W Steffes; Kenneth E Thummel; Russell P Tracy; Zhican Wang; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2014-04-03       Impact factor: 8.860

10.  Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man.

Authors:  P W Lambert; P H Stern; R C Avioli; N C Brackett; R T Turner; A Greene; I Y Fu; N H Bell
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.